APA

Hamada T., Sugaya M., Tokura Y., Ohtsuka M., Tsuboi R., Nagatani T., Tani M., Setoyama M., Matsushita S., Kawai K., Yonekura K., Yoshida T., Saida T. & Iwatsuki K. (20180314). Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas. : The Journal of dermatology.

Chicago

Hamada Toshihisa, Sugaya Makoto, Tokura Yoshiki, Ohtsuka Mikio, Tsuboi Ryoji, Nagatani Tetsuo, Tani Mamori, Setoyama Mitsuru, Matsushita Shigeto, Kawai Kazuhiro, Yonekura Kentaro, Yoshida Tsuyoshi, Saida Toshiaki and Iwatsuki Keiji. 20180314. Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas. : The Journal of dermatology.

Harvard

Hamada T., Sugaya M., Tokura Y., Ohtsuka M., Tsuboi R., Nagatani T., Tani M., Setoyama M., Matsushita S., Kawai K., Yonekura K., Yoshida T., Saida T. and Iwatsuki K. (20180314). Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas. : The Journal of dermatology.

MLA

Hamada Toshihisa, Sugaya Makoto, Tokura Yoshiki, Ohtsuka Mikio, Tsuboi Ryoji, Nagatani Tetsuo, Tani Mamori, Setoyama Mitsuru, Matsushita Shigeto, Kawai Kazuhiro, Yonekura Kentaro, Yoshida Tsuyoshi, Saida Toshiaki and Iwatsuki Keiji. Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas. : The Journal of dermatology. 20180314.